Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from EMPEROR-reduced

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zannad, Faiez (VerfasserIn) , Ferreira, João Pedro (VerfasserIn) , Pocock, Stuart J. (VerfasserIn) , Zeller, Cordula (VerfasserIn) , Anker, Stefan D. (VerfasserIn) , Butler, Javed (VerfasserIn) , Filippatos, Gerasimos (VerfasserIn) , Hauske, Sibylle J. (VerfasserIn) , Brückmann, Martina (VerfasserIn) , Pfarr, Egon (VerfasserIn) , Schnee, Janet (VerfasserIn) , Wanner, Christoph (VerfasserIn) , Packer, Milton (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 January 2021
In: Circulation
Year: 2021, Jahrgang: 143, Heft: 4, Pages: E29-E29
ISSN:1524-4539
DOI:10.1161/CIR.0000000000000953
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/CIR.0000000000000953
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000953
Volltext
Verfasserangaben:Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer

MARC

LEADER 00000caa a2200000 c 4500
001 1762486628
003 DE-627
005 20220820013050.0
007 cr uuu---uuuuu
008 210708s2021 xx |||||o 00| ||eng c
024 7 |a 10.1161/CIR.0000000000000953  |2 doi 
035 |a (DE-627)1762486628 
035 |a (DE-599)KXP1762486628 
035 |a (OCoLC)1341418252 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zannad, Faiez  |d 1951-  |e VerfasserIn  |0 (DE-588)141665009  |0 (DE-627)704036290  |0 (DE-576)182926400  |4 aut 
245 1 0 |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function  |b Insights from EMPEROR-reduced  |c Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer 
264 1 |c 26 January 2021 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.07.2021 
700 1 |a Ferreira, João Pedro  |e VerfasserIn  |4 aut 
700 1 |a Pocock, Stuart J.  |e VerfasserIn  |4 aut 
700 1 |a Zeller, Cordula  |e VerfasserIn  |4 aut 
700 1 |a Anker, Stefan D.  |e VerfasserIn  |4 aut 
700 1 |a Butler, Javed  |e VerfasserIn  |4 aut 
700 1 |a Filippatos, Gerasimos  |e VerfasserIn  |4 aut 
700 1 |a Hauske, Sibylle J.  |d 1976-2025  |e VerfasserIn  |0 (DE-588)137856253  |0 (DE-627)596151527  |0 (DE-576)305349686  |4 aut 
700 1 |a Brückmann, Martina  |d 1970-  |e VerfasserIn  |0 (DE-588)121145069  |0 (DE-627)705257290  |0 (DE-576)292557736  |4 aut 
700 1 |a Pfarr, Egon  |e VerfasserIn  |4 aut 
700 1 |a Schnee, Janet  |e VerfasserIn  |4 aut 
700 1 |a Wanner, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Packer, Milton  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Circulation  |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950  |g 143(2021), 4, Seite E29-E29  |h Online-Ressource  |w (DE-627)265784670  |w (DE-600)1466401-X  |w (DE-576)074891189  |x 1524-4539  |7 nnas  |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reduced 
773 1 8 |g volume:143  |g year:2021  |g number:4  |g pages:E29-E29  |g extent:1  |a Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reduced 
787 0 8 |i Errata zu  |a Zannad, Faiez, 1951 -   |t Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function  |d 2021  |w (DE-627)1762482657 
856 4 0 |u https://doi.org/10.1161/CIR.0000000000000953  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/CIR.0000000000000953  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220420 
993 |a Article 
994 |a 2021 
998 |g 121145069  |a Brückmann, Martina  |m 121145069:Brückmann, Martina  |d 60000  |e 60000PB121145069  |k 0/60000/  |p 9 
998 |g 137856253  |a Hauske, Sibylle J.  |m 137856253:Hauske, Sibylle J.  |d 60000  |d 61400  |e 60000PH137856253  |e 61400PH137856253  |k 0/60000/  |k 1/60000/61400/  |p 8 
999 |a KXP-PPN1762486628  |e 4119034364 
BIB |a Y 
SER |a newspaper 
JSO |a {"id":{"doi":["10.1161/CIR.0000000000000953"],"eki":["1762486628"]},"physDesc":[{"extent":"1 S."}],"note":["Gesehen am 08.07.2021"],"relHost":[{"disp":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function Insights from EMPEROR-reducedCirculation","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["265784670"],"issn":["1524-4539"],"zdb":["1466401-X"]},"note":["Gesehen am 10.10.2025"],"corporate":[{"role":"isb","display":"American Heart Association"}],"type":{"media":"Online-Ressource","bibl":"newspaper"},"origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1950","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-"}],"recId":"265784670","title":[{"title":"Circulation","subtitle":"an official journal of the American Heart Association","title_sort":"Circulation"}],"part":{"volume":"143","year":"2021","text":"143(2021), 4, Seite E29-E29","pages":"E29-E29","extent":"1","issue":"4"},"language":["eng"],"pubHistory":["1.1950 -"]}],"recId":"1762486628","origin":[{"dateIssuedDisp":"26 January 2021","dateIssuedKey":"2021"}],"type":{"media":"Online-Ressource","bibl":"article-newspaper"},"person":[{"given":"Faiez","role":"aut","display":"Zannad, Faiez","family":"Zannad"},{"family":"Ferreira","given":"João Pedro","role":"aut","display":"Ferreira, João Pedro"},{"given":"Stuart J.","role":"aut","display":"Pocock, Stuart J.","family":"Pocock"},{"given":"Cordula","role":"aut","display":"Zeller, Cordula","family":"Zeller"},{"family":"Anker","given":"Stefan D.","role":"aut","display":"Anker, Stefan D."},{"family":"Butler","display":"Butler, Javed","given":"Javed","role":"aut"},{"display":"Filippatos, Gerasimos","role":"aut","given":"Gerasimos","family":"Filippatos"},{"family":"Hauske","given":"Sibylle J.","role":"aut","display":"Hauske, Sibylle J."},{"family":"Brückmann","role":"aut","given":"Martina","display":"Brückmann, Martina"},{"family":"Pfarr","role":"aut","given":"Egon","display":"Pfarr, Egon"},{"display":"Schnee, Janet","role":"aut","given":"Janet","family":"Schnee"},{"family":"Wanner","display":"Wanner, Christoph","role":"aut","given":"Christoph"},{"family":"Packer","given":"Milton","role":"aut","display":"Packer, Milton"}],"name":{"displayForm":["Faiez Zannad, João Pedro Ferreira, Stuart J. Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle Jenny Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner and Milton Packer"]},"title":[{"title":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function","subtitle":"Insights from EMPEROR-reduced","title_sort":"Correction to: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function"}],"language":["eng"]} 
SRT |a ZANNADFAIECORRECTION2620